That is why NUH will struggle to obtain authority in the hearing...

First 40 Last

Share
Profile

Follow
kickit2me

4,638 Posts.

1144

04/05/18

18:17

Post #: 32895247
Share

Originally posted by bruutz82 ↑

1) NUHs branding in the twitterverse is obviously not that great because you are a production stage stock with fairly low receipts in your last quarter. If it is so great perhaps your receipts should have been higher? NTI is a development stage stock so for us it is all about meeting our full study publication end point milestone and then FDA submission milestone.

2) Your comment about publications dont sell product further indicates to me that you don't understand the medical device market. Twitterverse is the last place that will help NTI obtain the authority in the autism field.

But hey, thats the difference between NTI and NUH right? NTI is in the medical device market and NUH is in the electronic consumerables market.

That is why NUH will struggle to obtain authority in the hearing aid market and also in the medical field of Auditory Processing Disorder.

NUHs attempt to indicate that it was going to lead in the APD field when all it does is amplify sound was embarrasing. It does not even resolve the underlying condition.

That is the obvious difference between NUH and NTI.

Expand

That is why NUH will struggle to obtain authority in the hearing aid market.

What about these three recent measures of authority?

Australian Government approves Nuheara as a registered device supplier under the Hearing Services Program (HSP):
http://www.aspecthuntley.com.au/doc...Jyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true

Globally renowned research organisation, National Acoustic Laboratories (NAL), has clinically validated the validity and reliability of Nuheara’s proprietary hearing assessment technology, Ear ID™:
http://www.aspecthuntley.com.au/doc...Jyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true

Nuheara continues Hearing Health Care channel expansion: (Connect Hearing are part of Sonova - look them up):
http://www.aspecthuntley.com.au/doc...Jyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true

NTI Price at posting: 19.0¢ Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PYC

Scientific conference spotlights PYC's work on blindness disease treatment

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

HotCopper Highlights: Your most watched stocks for Week 47, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

DUI

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

First 40 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 6.9¢		Change 0.002(2.99%)		Mkt cap ! $64.55M

Open	High	Low	Value	Volume
6.7¢	7.2¢	6.7¢	$45.29K	648.2K

Buyers (Bids)

No.	Vol.	Price($)
3	684701	6.6¢

Sellers (Offers)

Price($)	Vol.	No.
6.9¢	100000	1

View Market Depth

No.	Vol.	Price($)
4	589299	0.070
1	36231	0.069
5	240000	0.068
2	255000	0.067
3	262000	0.066

Price($)	Vol.	No.
0.072	100000	1
0.074	40000	1
0.075	738582	2
0.076	90000	1
0.077	190000	3

Last trade - 15.37pm 22/11/2024 (20 minute delay)

NTI (ASX) Chart

That is why NUH will struggle to obtain authority in the hearing...

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Scientific conference spotlights PYC's work on blindness disease treatment

Sales growth pushes Lovisa's fortunes (and shares) upwards

HotCopper Highlights: Your most watched stocks for Week 47, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Buyers (Bids)

Sellers (Offers)